3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
1
Classical hematology
1
Conditions
Neoplasms
68
Venous Thromboembolism
60
Anemia
33
Leukemia, Myeloid, Acute
28
Anemia, Sickle Cell
26
Multiple Myeloma
25
Hematologic Neoplasms
25
Myelodysplastic Syndromes
24
Febrile Neutropenia
24
Leukemia
22
Lymphoma
19
Anemia, Aplastic
19
Thrombocytopenia
17
Myeloproliferative Disorders
16
Breast Neoplasms
16
Anemia, Refractory, with Excess of Blasts
16
Neutropenia
14
Venous Thrombosis
13
Lymphoma, Non-Hodgkin
13
Precursor Cell Lymphoblastic Leukemia-Lymphoma
12
Neoplasms, Plasma Cell
12
Lung Neoplasms
12
Hodgkin Disease
12
Fanconi Anemia
12
Colorectal Neoplasms
12
Ovarian Neoplasms
11
Leukemia, Lymphocytic, Chronic, B-Cell
10
Thrombosis
9
Pulmonary Embolism
9
Pancreatic Neoplasms
9
Interventions
edoxaban
1
apixaban
1
Rivaroxaban
1
Heparin, Low-Molecular-Weight
1
Dabigatran
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Embolism
×
Classical hematology
×
Clear all
NCT04618913
2026-05-26
VICTORIE
Pfizer
Active not recruiting
1 enrolled